Home > Insider Trading > Filing (0001415889-24-017361)

Filing Details

Accession Number:: 0001415889-24-017361
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-06-18 16:00:07
Reporting Period:: 2024-06-17

Accepted Time:: 2024-06-18 16:00:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Eli Lilly & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
316011	Lilly Endowment Inc	2801 North Meridian Street Indianapolis IN 46208-0068		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-06-17	36,716	$882.45	97,742,072	No	4	S	Direct
Common Stock	Disposition	2024-06-17	22,282	$883.43	97,719,790	No	4	S	Direct
Common Stock	Disposition	2024-06-17	11,820	$884.56	97,707,970	No	4	S	Direct
Common Stock	Disposition	2024-06-17	27,351	$885.58	97,680,619	No	4	S	Direct
Common Stock	Disposition	2024-06-17	17,513	$886.60	97,663,106	No	4	S	Direct
Common Stock	Disposition	2024-06-17	38,194	$887.47	97,624,912	No	4	S	Direct
Common Stock	Disposition	2024-06-17	18,293	$888.52	97,606,619	No	4	S	Direct
Common Stock	Disposition	2024-06-17	15,342	$889.36	97,591,277	No	4	S	Direct
Common Stock	Disposition	2024-06-17	6,121	$890.50	97,585,156	No	4	S	Direct
Common Stock	Disposition	2024-06-17	1,300	$891.54	97,583,856	No	4	S	Direct
Common Stock	Disposition	2024-06-17	46	$892.14	97,583,810	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $882.00 to $882.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $883.00 to $883.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $884.00 to $884.965, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $885.00 to $885.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $886.00 to $886.995, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $887.00 to $887.995, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $888.00 to $888.995, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $889.00 to $889.985, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $890.00 to $890.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $891.08 to $892.055, inclusive.